-The Independent Drought is good for business, says Glencore chief The United Nations, aid agencies and the British Government have lined up to attack the world's largest commodities trading company, Glencore, after it described the current global food crisis and soaring world prices as a "good" business opportunity. With the US experiencing a rerun of the drought "Dust Bowl" days of the 1930s and Russia suffering a similar food crisis that could see...
More »SEARCH RESULT
Total Matching Records found : 2068
1144 Deaths During Clinical Drug Trials in 2 Years: Govt
-PTI Clinical drug trials in India led to the death of 1144 people in 2010 and 2011, the government today said. The number of people dying during such trials also include 1106 people whose death could be attributed to diseases like cancer, terminal illness or various unrelated causes which is also known as Serious Adverse Event (SAE) of death, Health and Family Welfare Minister Ghulam Nabi Azad told the Rajya Sabha. "The number...
More »Street vendors hail new Bill
-The Hindu A day after the Union Cabinet approved the Street Vendors (Protection of Livelihood & Regulation of Street Vending) Bill, 2012, the National Association of Street Vendors of India organised a meeting at Jantar Mantar on Saturday and hailed the decision with the hope that Parliament would now pass the Bill in its current session. Association national coordinator Arbind Singh said, “The struggle of street vendors has yielded result. We have...
More »This expensive bulb is fused-Surya P Sethi
-The Hindu Universal electrification will remain a dream unless the government fixes the flaws in its much vaunted scheme to provide power to rural India In his Independence Day speech, the Prime Minister made the statement that “when the UPA Government came to power in 2004, we had promised that we would provide electricity to all villages.” He then went on to say: “Our next target is to provide electricity to each...
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »
